These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species. Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951 [TBL] [Abstract][Full Text] [Related]
3. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies. Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223 [TBL] [Abstract][Full Text] [Related]
4. Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics. Ravuluri S; Bansal R; Chhabra N; Rathore AS Pharm Res; 2018 May; 35(7):142. PubMed ID: 29761239 [TBL] [Abstract][Full Text] [Related]
5. Effect of buffer species on the unfolding and the aggregation of humanized IgG. Kameoka D; Masuzaki E; Ueda T; Imoto T J Biochem; 2007 Sep; 142(3):383-91. PubMed ID: 17646171 [TBL] [Abstract][Full Text] [Related]
6. Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE. Kirley TL; Greis KD; Norman AB Biochem Biophys Rep; 2018 Dec; 16():138-144. PubMed ID: 30417132 [TBL] [Abstract][Full Text] [Related]
7. Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE. Liu H; Gaza-Bulseco G; Chumsae C; Newby-Kew A Biotechnol Lett; 2007 Nov; 29(11):1611-22. PubMed ID: 17609855 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment. Kirley TL; Norman AB Hum Vaccin Immunother; 2015; 11(2):458-67. PubMed ID: 25692880 [TBL] [Abstract][Full Text] [Related]
9. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. Ionescu RM; Vlasak J; Price C; Kirchmeier M J Pharm Sci; 2008 Apr; 97(4):1414-26. PubMed ID: 17721938 [TBL] [Abstract][Full Text] [Related]
10. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates. Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308 [TBL] [Abstract][Full Text] [Related]
11. Multi-domain unfolding of the Fab fragment of a humanized anti-cocaine mAb characterized by non-reducing SDS-PAGE. Kirley TL; Norman AB Biochem Biophys Res Commun; 2020 Dec; 533(3):580-585. PubMed ID: 32988582 [TBL] [Abstract][Full Text] [Related]
12. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability. Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456 [TBL] [Abstract][Full Text] [Related]
13. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody. Toth RT; Pace SE; Mills BJ; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB J Pharm Sci; 2018 Apr; 107(4):1009-1019. PubMed ID: 29269271 [TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of CHO host cell protease-induced fragmentation of a recombinant monoclonal antibody during production process development. Yang B; Li W; Zhao H; Wang A; Lei Y; Xie Q; Xiong S J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():1-10. PubMed ID: 30836312 [TBL] [Abstract][Full Text] [Related]
16. Thermodynamic Unfolding and Aggregation Fingerprints of Monoclonal Antibodies Using Thermal Profiling. Melien R; Garidel P; Hinderberger D; Blech M Pharm Res; 2020 Apr; 37(4):78. PubMed ID: 32236701 [TBL] [Abstract][Full Text] [Related]
18. Monitoring of IgG antibody thermal stability by micellar electrokinetic capillary chromatography and matrix-assisted laser desorption/ionization mass spectrometry. Alexander AJ; Hughes DE Anal Chem; 1995 Oct; 67(20):3626-32. PubMed ID: 8644915 [TBL] [Abstract][Full Text] [Related]
19. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Qian J; Liu T; Yang L; Daus A; Crowley R; Zhou Q Anal Biochem; 2007 May; 364(1):8-18. PubMed ID: 17362871 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods. Li W; Yang B; Zhou D; Xu J; Li W; Suen WC J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]